IL1B and metastatic neoplasm: Interestingly, in the “mixed cohorts” patients, those who presented with metastatic disease had a higher median level of IL-1β than those presenting with localized disease (1.23 pg/mL vs. 1.10 pg/mL; p = 0.022).